1 |
P.A Insel, Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. In: Goodman & Gilman s The pharmacological basis of therapeutics, 9th Edition, J.G Hardman,L.E. Limbird, P.B. Molinoff, R.W Ruddon and A.G. Gilman (eds.), McGraw-Hill, New York, USA, pp. 617-657 (1996)
|
2 |
A. Karata,N. Yuksel and T. Baykara,Improved solubility and dissolution rate of piroxicam using gelucire44/14 and labrasol, Il Farmaco, 60, 777-782 (2005)
DOI
ScienceOn
|
3 |
M. Fernandez, I. C. Rodriguez, M. V. Margaritand A. Cerezo, Characterization of solid dispersions of piroxicam/polyethylene glycol 4000, Int. J. Pharm., 84, 197-202 (1992)
|
4 |
V. Tantishaiiyakul, N. Kaewnopparat and S. Ingkatawomwong, Properties of solid dispersions of piroxicam in polyvinyl- pyrrolidone, Int. J Pharm., 181, 143-151 (1999)
DOI
ScienceOn
|
5 |
H.-S. Gwak, J.-S. Choi and H.-K. Choi, Enhancedbioavailability of piroxicam via salt formation with ethanolamines, Int. J Pharm., 297, 156-161 (2005)
|
6 |
S. M. Wong, I. W Kellaway and S. Murdan, Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing micro- particles, Int. J Pharm., 317, 61-68 (2006)
DOI
ScienceOn
|
7 |
S.-C. Shin and C.-W Cho, Physicochemical characterizations of piroxicam-poloxamer solid dispersion, Pharm. Dev. Technol., 2, 403-407 (1997)
DOI
|
8 |
M. Fathy and M. El-Badry, Preparation and evaluation of piroxicam-pluronic solid dispersions, Bull. Pharm. Sci., 26, 97-108 (2003)
|
9 |
E.-J. Kim, M.-K. Chun,J.-S. Jang, I.-H. Lee,K.-R.Lee and H.K. Choi, Preparation of a solid dispersion of felodipine using a solvent wetting method,Eur. J Pharm. Biopharm., 64, 200-205 (2006)
DOI
ScienceOn
|
10 |
J. H. Collettand H. Popli, Poloxamer. In: Handbook of Pharmaceutical Excipients, 3rd Edition, A H. Kibbe, (ed.), American Pharmaceutical Association, Washington DC, USA, pp. 386-388 (2000)
|
11 |
C. Leuner and J. Dressman, Improving drug solubility for oral deliveryusing solid dispersions, Eur. J Pharm. Biopharm., 50, 47-60 (2000)
DOI
ScienceOn
|
12 |
M. Jug and M. Beirevi-Laan, Influence of hydroxypropyl-l3cyclodextrin complexation on piroxicam release from buccoadhesive tablets, Eur. J Pharm. Sci., 21, 251-260 (2004)
DOI
ScienceOn
|
13 |
S. Prabhu, M. Ortega and C. Ma, Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxi- cam, Int. J Pharm., 301, 209-216 (2005)
DOI
ScienceOn
|